Anavex Life Sciences
AVXL
178 hedge funds and large institutions have $302M invested in Anavex Life Sciences in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 70 increasing their positions, 33 reducing their positions, and 25 closing their positions.
112% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 33
25% more call options, than puts
Call options by funds: $14.9M | Put options by funds: $12M
12% more capital invested
Capital invested by funds: $270M → $302M (+$32.3M)
1.13% more ownership
Funds ownership: 36.93% → 38.06% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 25
2% less funds holding
Funds holding: 181 → 178 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$2.75M |
| 2 |
Two Sigma Advisers
New York
|
+$2.69M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$2.64M |
| 4 |
BlackRock
New York
|
+$2.55M |
| 5 |
SF
Summit Financial
Parsippany,
New Jersey
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.92M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.27M |
| 3 |
Morgan Stanley
New York
|
-$2.03M |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$1.95M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.54M |
AVXL Hedge Fund Activity: Q2 2025 in Review
178 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q2 2025, worth a combined $302M — up 12% from $270M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of AVXL and 24 opened new positions — a net loss of 1 holder — while 33 trimmed existing stakes and 70 added.
The largest buyer was Citadel Advisors, adding an estimated $2.75M. The largest seller was Millennium Management, exiting entirely with an estimated $2.92M sold.
- 178 institutional investors held Anavex Life Sciences (AVXL) as of Q2 2025, down from 181 in Q1 2025.
- Funds reported $302M of Anavex Life Sciences stock for Q2 2025, up 12% quarter-over-quarter.
- 24 funds opened new Anavex Life Sciences positions in Q2 2025 and 25 closed out, a net change of -1 holder.
- The largest Anavex Life Sciences buyer in Q2 2025 was Citadel Advisors, an estimated $2.75M added.
- The largest Anavex Life Sciences seller in Q2 2025 was Millennium Management, an estimated $2.92M sold.
Based on aggregated 13F filings for Q2 2025.